Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| MANNKIND CORPMNKD · Entity 4792 | Director | August 28, 2017 | August 30, 2017 |
| Vivani Medical, Inc.EYES · Entity 6636 | Director | June 04, 2019 | June 05, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
MANNKIND CORP
Report date August 28, 2017 · Filed August 30, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 81,961 |
Reported balance
After 2017-08-28 transaction · row 1
1 source rowRow 1 · 2017-08-28 · Tax withholding · Disposed 303 · Balance 81,961 F1: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units.
Vivani Medical, Inc.
Report date June 04, 2019 · Filed June 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Qualified Stock Option(right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2029-06-04 | Direct | 56,685 |
Reported balance
After 2019-06-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2019-06-04 · Grant · Acquired 56,685 · Balance 56,685 F1: The stock options have a 10-year term and fully vest on the earlier of annual grant date anniversary or the date of the next annual shareholder's meeting. F2: Awarded as compensation for serving on the Board of Directors and its committees. |
Filing footnotes · ownership attribution and instrument terms
F1: The stock options have a 10-year term and fully vest on the earlier of annual grant date anniversary or the date of the next annual shareholder's meeting.
F2: Awarded as compensation for serving on the Board of Directors and its committees.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 04, 2019 Filed Jun 5, 2019 20:16 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon-Qualified Stock Option(right to buy) · Derivative | 56,685 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001209191-19-034732 · doc4.xml · derivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,685 Underlying: Common Stock · 56,685 shares Expires 2029-06-04 F1 · derivative.exercise_date: The stock options have a 10-year term and fully vest on the earlier of annual grant date anniversary or the date of the next annual shareholder's meeting. F2 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 02, 2018 Filed Jun 6, 2018 01:00 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantNon Qualified Stock Option (right to buy) · Derivative | 25,970 | $0.00 Strike: $2.05 | $0.00 |
DisclosureSEC source: 0001437749-18-011320 · rdgdoc.xml · derivative · entry 2 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,970 Underlying: Common Stock · 25,970 shares Expires 2028-06-02 F1 · derivative.underlying_shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| June 01, 2018 Filed Jun 6, 2018 01:00 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 35,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-18-011320 · rdgdoc.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,301 F1 · shares: Awarded as compensation for serving on the Board of Directors and its committees. Read SEC document |
| August 28, 2017 Filed Aug 30, 2017 01:08 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 303 | $1.55 | $469.65 |
DisclosureSEC source: 0001209191-17-050658 · doc4.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,961 F1 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 22, 2017 Filed Aug 23, 2017 23:07 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 170 | $1.41 | $239.70 |
DisclosureSEC source: 0001209191-17-050010 · doc4.xml · nonDerivative · entry 3 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,264 F2 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| August 21, 2017 Filed Aug 23, 2017 23:07 UTC | MANNKIND CORP MNKD · Entity 4792 | Tax withholdingCommon Stock, $.01 Par Value | 183 | $1.46 | $267.18 |
DisclosureSEC source: 0001209191-17-050010 · doc4.xml · nonDerivative · entry 2 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,434 F2 · kind: Shares withheld to satisfy the tax liability incident to the vesting of previously reported restricted stock units. Read SEC document |
| June 30, 2017 Filed Aug 23, 2017 23:07 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $.01 Par Value | 2,000 | $1.23 | $2,460.00 |
DisclosureSEC source: 0001209191-17-050010 · doc4.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,617 F1 · kind: Shares acquired through the Issuer's Employee Stock Purchase Plan Read SEC document |
| June 01, 2017 Filed Jun 6, 2017 00:20 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCommon Stock | 59,725 | $1.17 | $69,997.70 |
DisclosureSEC source: 0001615774-17-002941 · s106449_form4.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,768 F1 · shares: Awarded to Mr. Pfeffer as compensation for serving on the Board of Directors and its committees. F2 · price: Price per share constitutes an average closing price of Company's stock for the preceding twenty trading days on its principal exchange. Read SEC document |
| March 14, 2017 Filed Mar 17, 2017 00:31 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantWarrant to Purchase Common Stock · Derivative | 5,582 | Not disclosed Strike: $1.47 | Not disclosed |
DisclosureSEC source: 0001615774-17-001110 · s105599_form4.xml · derivative · entry 2 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,582 Underlying: Common Stock · 5,582 shares Expires 2022-03-14 F1 · shares: Mr. Pfeffer acquired common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocations of units were confirmed on March 14, 2017. F1 · price: Mr. Pfeffer acquired common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocations of units were confirmed on March 14, 2017. Read SEC document |
| March 14, 2017 Filed Mar 17, 2017 00:31 UTC | Vivani Medical, Inc. EYES · Entity 6636 | GrantCOMMON STOCK | 5,582 | $1.47 | $8,205.54 |
DisclosureSEC source: 0001615774-17-001110 · s105599_form4.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,043 F1 · shares: Mr. Pfeffer acquired common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocations of units were confirmed on March 14, 2017. F1 · price: Mr. Pfeffer acquired common stock and warrants reported on this Form 4 pursuant to an exercise of subscription rights previously distributed by the Company to all holders of the Company's common stock. Each stockholder received a right to invest $0.47 for every share held of record on February 10, 2017, the record date, to purchase units consisting of one share of common stock and one warrant to purchase one share of common stock. The final allocations of units were confirmed on March 14, 2017. Read SEC document |
| January 03, 2017 Filed Jan 4, 2017 18:21 UTC | MANNKIND CORP MNKD · Entity 4792 | PurchaseCommon Stock, $.01 Par Value | 4,540 | $0.54 | $2,451.60 |
DisclosureSEC source: 0001209191-17-000658 · doc4.xml · nonDerivative · entry 1 PFEFFER MATTHEW J · CIK 0001192063 · CEO, CFO, Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 403,085 F1 · shares: Shares acquired through the Issuer's Employee Stock Purchase Plan Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.